Back

The left bundle branch pacing-shock lead will become standard in implantable cardioverter-defibrillator therapy: discussion

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Debate on cardiac implantable electronic device therapy Device Therapy EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

5 More presentations in this session

Presentation thumbnail
Implantable cardioverter-defibrillator therapy is indicated in all patients with ischaemic cardiomyopathy and severe systolic dysfunction: pro
Professor C. Sticherling (Basel, CH)
Slides Video
Presentation thumbnail
Implantable cardioverter-defibrillator therapy is indicated in all patients with ischaemic cardiomyopathy and severe systolic dysfunction: con
Doctor N. Dagres (Berlin, DE)
Video
Presentation thumbnail
Implantable cardioverter-defibrillator therapy is indicated in all patients with ischaemic cardiomyopathy and severe systolic dysfunction: discussion
Video
Presentation thumbnail
The left bundle branch pacing-shock lead will become standard in implantable cardioverter-defibrillator therapy: pro
Doctor J. Karvonen (Helsinki, FI)
Slides Video
Presentation thumbnail
The left bundle branch pacing-shock lead will become standard in implantable cardioverter-defibrillator therapy: con
Associate Professor G. Upadhyay (Chicago, US)
Slides Video

Access the full session

Session thumbnail
Debate on cardiac implantable electronic device therapy
Video

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
The left bundle branch pacing-shock lead will become standard in implantable cardioverter-defibrillator therapy: con
thumbnail
Congress Presentation
Debating the future of implantable cardioverter-defibrillator therapy: discussion
thumbnail
Congress Session
Debate on cardiac implantable electronic device therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources